Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells

Blood

Volumn 100, Issue 12, 2002, Pages 3960-3967

  Horn, Peter A ^a,b   Topp, Max S ^a,b   Morris, Julia C ^a,b   Riddell, Stanley R ^a,b   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BABOON; BONE MARROW CELL; CELL LINE; CELL POPULATION; CELL STRAIN 3T3; DNA PACKAGING; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TRANSGENE;

EID: 0036892648     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1359     Document Type: Article

References (38)

1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease. Science. 2000;288:669-672.
2. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature. 1990;347:188-189.
3. + cells emphasize limited transduction at low receptor levels. Gene Ther. 2001;B:593-599.
4. Tisdale JF, Hanazono Y, Sellers SE, et al. Ex vivo expansion of genetically marked Rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood. 1998;92: 1131-1141.
5. Xu LC, Young HA, Blanco M, Kessler S, Roberts AB, Karlsson S. Poor transduction efficiency of human hematopoietic progenitor cells by a high-titer amphotropic retrovirus producer cell clone. J Virol. 1994; 68:7634-7636.
6. Le Doux JM, Morgan JR, Snow RG, Yarmush ML. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol. 1996;70:6468-6473.
7. Le Doux JM, Morgan JR, Yarmush ML. Removal of proteoglycans increases efficiency of retroviral gene transfer. Biotechnol Bioeng. 1998;58:23-34.
8. Forestell SP, Dando JS, Chen J, de Vries P, Bohnlein E, Rigg RJ. Novel retroviral packaging cell lines: Complementary tropisms and improved vector production for efficient gene transfer. Gene Ther. 1997;4:600-610.
9. Kiem H-P, Heyward S, Winkler A, et al. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood. 1997;90:4638-4645.
10. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol. 1994;68: 510-516.
11. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272: 263-267.
12. Woods NB, Fahlman C, Mikkola H, et al. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood. 2000;96: 3725-3733.
13. Guenechea G, Gan OI, Inamitsu T, et al. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther. 2000;1:566-573.
14. Kiem H-P, Andrews RG, Morris J, et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood. 1998;92: 1878-1886.
15. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet. 2000;25:217-222.
16. Kurre P, Morris J, Horn PA, Harkey MA, Andrews RG, Kiem H-P. Gene transfer into baboon repopulating cells: A comparison of flt-3 ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction. Mol Ther. 2001;3:920-927.
17. Davis JL, Witt RM, Gross PR, et al. Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies. Hum Gene Ther. 1997;8: 1459-1467.
18. Kelly PF, Vandergriff J, Nathwani A, Nienhuis AW, Vanin EF. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood. 2000;96:1206-1214.
19. Rigg RJ, Chen J, Dando JS, Forestell SP, Plavec I, Bohnlein E. A novel human amphotropic packaging cell line: High titer, complement resistance, and improved safety. Virology. 1996;218:290-295.
20. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993;90:8392-8396.
21. An DS, Wersto RP, Agricola BA, et al. Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J Virol, 2000;74:1286-1295.
22. An DS, Kung SK, Bonifacino A, et al. Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J Virol. 2001;75: 3547-3555.
23. Horn PA, Morris JC, Bukovsky AA, et al. Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther. 2002; 9:1464-1471,
24. Scherr M, Battmer K, Blomer U, et al. Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells. Blood. 2002;99:709-712.
25. Horn PA, Morris JC,Topp MS, Peterson L, Kiem H-P. Direct comparison of gene transfer efficiencies into hematopoietic repopulating cells as measured by the NOD/SCID xenotransplant system versus autologous transplantation in the baboon suggests that distinct stem/progenitor cells are assayed [abstract]. Blood. 2001;98(part 1): 816a. Abstract 3393.
26. Abonour R, Williams DA, Einhorn L, et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000;6:652-658.
27. Goerner M, Bruno B, McSweeney PA, Buron G, Storb R, Kiem H-P. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. Blood. 1999;94:2287-2292.
28. Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood. 1999;94:3349-3357.
29. Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood. 2000;96:894-901.
30. Robbins PB, Skelton DC, Yu XJ, Halene S, Leonard EH, Kohn DB. Consistent, persistent expression from modified retroviral vectors in murine hematopoieitic stem cells. Proc Natl Acad Sci U S A. 1998;95:10182-10187.
31. Kurre P, Morris J, Andrews RG, Kohn DB, Kiem H-P. Kinetics of fluorescence expression in non-human primates transplanted with GFP retrovirus-modified CD34 cells. Mol Ther. 2002;6:83-90.
32. Donahue RE, Wersto RP, Allay JA, et al. High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells. Blood. 2000;95:445-452.
33. Rosenzweig M, MacVittie TJ, Harper D, et al. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood. 1999;94:2271-2286.
34. Karpen GH. Position-effect variegation and the new biology of heterochromatin. Curr Opin Genet Dev. 1994;4:281-291.
35. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: Pitfalls and potential. Biotechniques. 1999;26:112-122.
36. Sellers SE, Tisdale JF, Bodine DM, et al. No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells. Hum Gene Ther. 1999;10:633-640.
37. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1995;1:1017-1023.
38. Brenner M. Gene marking. Hum Gene Ther. 1996;7:1927-1936.